Rob C. Holmes, holding the titles of Chairman, President, and CEO at Texas Capital Bancshares Inc. (NASDAQ: TCBI), has executed a substantial reduction in his equity position within the company. According to a recent SEC Form 4 filing dated June 8, 2026, Holmes disposed of a total of 98,600 shares of the company’s common stock. The aggregate value of these transactions was calculated at approximately $10,012,698.
The disposition of these shares was not a single event but occurred across two distinct dates. On June 5, 2026, Mr. Holmes sold 49,100 shares. The average price for this initial tranche was $101.88 per share, with individual transaction prices fluctuating between $101.00 and $102.74. This portion of the sale generated proceeds of approximately $5,002,428.
A follow-up transaction took place on June 8, 2026, involving the sale of 49,500 shares. These shares were divested at an average price of $101.22, with prices ranging from $100.61 to $102.55. This second batch of sales contributed approximately $5,009,490 to the total proceeds. Following these sales, Mr. Holmes indirectly retains a holding of 167,635 shares of Texas Capital Bancshares common stock. All shares sold were held indirectly through CRH1990, Ltd. This entity is owned by Mr. Holmes at 49.95%, his spouse at 49.95%, and Bryn Mawr Management, LLC at 0.01%, which acts as the general partner. Bryn Mawr Management, LLC is equally owned by Mr. Holmes and his spouse.
The timing of this insider activity is notable given the recent financial performance of Texas Capital Bancshares. The company reported earnings per share (EPS) of $1.58 for the first quarter of 2026. This figure exceeded the consensus analyst expectations of $1.40, highlighting the firm's capacity to outperform market projections. Despite this positive earnings report, the company’s stock experienced a decline in pre-market trading.
Market data from InvestingPro indicates that the stock is currently trading at $100.59. Over the past year, the stock has appreciated by 32.55%. However, InvestingPro analysis suggests that the stock remains undervalued, with a calculated Fair Value of $130.23. This valuation places TCBI among opportunities identified on the Most Undervalued list. Investors seeking deeper insights can access a comprehensive Pro Research Report available for TCBI and over 1,400 other US equities.
The divergence between the strong financial results and the recent stock performance, coupled with significant insider selling, presents a complex picture for stakeholders. The robust earnings performance demonstrates financial strength, yet the analyst community had projected lower earnings, making the actual results a significant achievement. The subsequent pre-market decline and insider divestment warrant close attention as the market digests these developments.